Sipai Health Technology Co., Ltd. (FRA:AX1)
Germany · Delayed Price · Currency is EUR 0.2700
+0.0080 (3.05%)
Last updated: Jan 27, 2026, 8:10 AM CET
Sipai Health Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 3,426 | 4,565 | 4,712 | 4,119 | 3,474 | 2,700 | |
Revenue Growth (YoY) | -26.14% | -3.11% | 14.39% | 18.58% | 28.68% | 159.83% |
Cost of Revenue | 3,093 | 4,180 | 4,300 | 3,786 | 3,193 | 2,512 |
Gross Profit | 332.69 | 385.53 | 412.45 | 333.97 | 281.06 | 188.11 |
Selling, General & Admin | 534.03 | 602.32 | 640.11 | 907.86 | 961.48 | 544.69 |
Research & Development | 12.33 | 22.26 | 45.95 | 62.65 | 59.21 | 45.74 |
Other Operating Expenses | 16.66 | - | - | - | 0.66 | 7.06 |
Operating Expenses | 597.61 | 659.88 | 696.02 | 975.98 | 1,028 | 602.82 |
Operating Income | -264.91 | -274.35 | -283.57 | -642.01 | -746.69 | -414.71 |
Interest Expense | -2.37 | -3.07 | -3.49 | -4.04 | -3.69 | -3.53 |
Interest & Investment Income | 10.76 | 15.82 | 31.34 | 17.25 | 10.37 | 1.14 |
Earnings From Equity Investments | -0.09 | -0.19 | -0.41 | 0.33 | 0.14 | -0.07 |
Currency Exchange Gain (Loss) | - | - | -0.03 | 0.01 | 3.95 | -0.01 |
Other Non Operating Income (Expenses) | -52.75 | -54.11 | 24.34 | -759.7 | -3,038 | -656.71 |
EBT Excluding Unusual Items | -309.36 | -315.89 | -231.82 | -1,388 | -3,774 | -1,074 |
Merger & Restructuring Charges | -35.82 | -22.3 | - | - | - | - |
Impairment of Goodwill | -34.1 | -34.1 | -31.28 | - | - | - |
Gain (Loss) on Sale of Investments | 17.64 | 17.52 | 17.45 | 22.36 | 25.66 | 8.78 |
Gain (Loss) on Sale of Assets | -1.77 | -1.77 | -1 | -0.7 | -0.08 | 0.02 |
Asset Writedown | -5.03 | -5.03 | - | - | - | - |
Other Unusual Items | 0.58 | 0.92 | 0.98 | -1.93 | 0.37 | 24.24 |
Pretax Income | -367.85 | -360.64 | -245.67 | -1,368 | -3,748 | -1,041 |
Income Tax Expense | 0.47 | 1.19 | 1.04 | 3.32 | 0.83 | 1.18 |
Earnings From Continuing Operations | -368.32 | -361.83 | -246.71 | -1,372 | -3,749 | -1,042 |
Minority Interest in Earnings | 50.8 | 38.1 | -9.06 | 1.19 | 8.05 | -0.75 |
Net Income | -317.52 | -323.74 | -255.77 | -1,371 | -3,740 | -1,043 |
Net Income to Common | -317.52 | -323.74 | -255.77 | -1,371 | -3,740 | -1,043 |
Shares Outstanding (Basic) | 623 | 639 | 644 | 112 | 99 | 100 |
Shares Outstanding (Diluted) | 623 | 639 | 644 | 112 | 99 | 100 |
Shares Change (YoY) | -3.13% | -0.78% | 472.64% | 13.10% | -0.55% | - |
EPS (Basic) | -0.51 | -0.51 | -0.40 | -12.19 | -37.61 | -10.43 |
EPS (Diluted) | -0.51 | -0.51 | -0.40 | -12.19 | -37.61 | -10.43 |
Free Cash Flow | -124.99 | -67.91 | -138.86 | -186.02 | -638.5 | -204.11 |
Free Cash Flow Per Share | -0.20 | -0.11 | -0.22 | -1.65 | -6.42 | -2.04 |
Gross Margin | 9.71% | 8.44% | 8.75% | 8.11% | 8.09% | 6.97% |
Operating Margin | -7.73% | -6.01% | -6.02% | -15.58% | -21.49% | -15.36% |
Profit Margin | -9.27% | -7.09% | -5.43% | -33.27% | -107.67% | -38.63% |
Free Cash Flow Margin | -3.65% | -1.49% | -2.95% | -4.52% | -18.38% | -7.56% |
EBITDA | -253.07 | -259.52 | -267.49 | -626.62 | -726.84 | -396.3 |
EBITDA Margin | -7.39% | -5.68% | -5.68% | -15.21% | -20.92% | -14.68% |
D&A For EBITDA | 11.84 | 14.83 | 16.08 | 15.39 | 19.85 | 18.41 |
EBIT | -264.91 | -274.35 | -283.57 | -642.01 | -746.69 | -414.71 |
EBIT Margin | -7.73% | -6.01% | -6.02% | -15.58% | -21.49% | -15.36% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.